eperisone has been researched along with Paraparesis, Tropical Spastic in 2 studies
eperisone : A racemate that is an equimolar mixture of (R)- and (S)-eperisone. It is used (as the hydrochloride salt) as a muscle relaxant for the symptomatic treatment of muscle spasm and spasticity.
1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one : An aromatic ketone that is N-propylpiperidine in which a hydrogen at positon 2 of the propyl group is replaced by a p-ethylbenzoyl group.
Paraparesis, Tropical Spastic: A subacute paralytic myeloneuropathy occurring endemically in tropical areas such as the Caribbean, Colombia, India, and Africa, as well as in the southwestern region of Japan; associated with infection by HUMAN T-CELL LEUKEMIA VIRUS I. Clinical manifestations include a slowly progressive spastic weakness of the legs, increased reflexes, Babinski signs, incontinence, and loss of vibratory and position sensation. On pathologic examination inflammatory, demyelination, and necrotic lesions may be found in the spinal cord. (Adams et al., Principles of Neurology, 6th ed, p1239)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa, M | 2 |
| Nakahara, K | 1 |
| Maruyama, Y | 1 |
| Kawabata, M | 1 |
| Higuchi, I | 2 |
| Kubota, H | 1 |
| Izumo, S | 2 |
| Arimura, K | 2 |
| Osame, M | 2 |
| Umehara, F | 1 |
| Ijichi, S | 1 |
| Moritoyo, T | 1 |
| Usuku, K | 1 |
1 trial available for eperisone and Paraparesis, Tropical Spastic
| Article | Year |
|---|---|
Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/ tropical spastic paraparesis.
Topics: Administration, Oral; Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory A | 1996 |
1 other study available for eperisone and Paraparesis, Tropical Spastic
| Article | Year |
|---|---|
Recent studies on the epidemiology, clinical features and pathogenic mechanisms of HTLV-I associated myelopathy (HAM/TSP) and other diseases associated to HTLV.
Topics: Blood Component Removal; Blood-Brain Barrier; Brain; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymp | 1997 |